How can we ensure value for money from expenditure on injectable cancer drugs?

Peter J Gilbar^{1

2}, Carole R Chambers³

Affiliations

¹ 1 Cancer and Palliative Care Services, Toowoomba Hospital, Toowoomba, Australia.
² 2 Rural Clinical School, Faculty of Medicine, The University of Queensland, Toowoomba, Australia.
³ 3 Department of Cancer Services Pharmacy, Alberta Health Services, Alberta, Canada.

Comment

Peter J Gilbar et al. J Oncol Pharm Pract. 2018 Sep.

. 2018 Sep;24(6):473-476.

doi: 10.1177/1078155217706195. Epub 2017 Apr 29.

Peter J Gilbar^{1

2}, Carole R Chambers³

¹ 1 Cancer and Palliative Care Services, Toowoomba Hospital, Toowoomba, Australia.
² 2 Rural Clinical School, Faculty of Medicine, The University of Queensland, Toowoomba, Australia.
³ 3 Department of Cancer Services Pharmacy, Alberta Health Services, Alberta, Canada.

No abstract available

Keywords: Cancer drugs; drug wastage; expenditure; stability; vial sizes.

Comment on

Opportunities to significantly reduce expenditure associated with cancer drugs.
Gilbar PJ, Chambers CR, Gilbar EC. Gilbar PJ, et al. Future Oncol. 2017 Jun;13(15):1311-1322. doi: 10.2217/fon-2017-0033. Epub 2017 Jun 7. Future Oncol. 2017. PMID: 28589775